Dorman Products (NASDAQ: DORM) reported Q4 EPS of $1.33, $0.02 worse than the analyst estimate of $1.35. Revenue for the quarter came in at $398.2 million versus the consensus estimate of $367.45 million.

GUIDANCE:

Dorman Products sees FY2022 EPS of $5.35-$5.55, versus the consensus of $5.42.

• For fiscal 2022, the Company expects net sales growth of 19%-22%, diluted EPS of $4.94 to $5.14, and adjusted diluted EPS* of $5.35 to $5.55.

For earnings history and earnings-related data on Dorman Products (DORM) click here.